Typicality: | 0.320 |
Saliency: | 0.164 |
9–26 years of age | 4 | other |
vaccine → be recommended for → male | 7 |
vaccine → be recommended for → man | 3 |
negative | neutral | positive |
0.145 | 0.704 | 0.151 |
Raw frequency | 10 |
Normalized frequency | 0.164 |
Modifier score | 0.500 |
Perplexity | 96.487 |